These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 11056085

  • 1. Nitric oxide and viral cardiomyopathy.
    Finkel MS.
    Circulation; 2000 Oct 31; 102(18):2162-4. PubMed ID: 11056085
    [No Abstract] [Full Text] [Related]

  • 2. Nitric oxide donors inhibit the coxsackievirus B3 proteinases 2A and 3C in vitro, virus production in cells, and signs of myocarditis in virus-infected mice.
    Zell R, Markgraf R, Schmidtke M, Görlach M, Stelzner A, Henke A, Sigusch HH, Glück B.
    Med Microbiol Immunol; 2004 May 31; 193(2-3):91-100. PubMed ID: 14513374
    [Abstract] [Full Text] [Related]

  • 3. Nitric oxide inhibits dystrophin proteolysis by coxsackieviral protease 2A through S-nitrosylation: A protective mechanism against enteroviral cardiomyopathy.
    Badorff C, Fichtlscherer B, Rhoads RE, Zeiher AM, Muelsch A, Dimmeler S, Knowlton KU.
    Circulation; 2000 Oct 31; 102(18):2276-81. PubMed ID: 11056105
    [Abstract] [Full Text] [Related]

  • 4. Cleavage of osmosensitive transcriptional factor NFAT5 by Coxsackieviral protease 2A promotes viral replication.
    Qiu Y, Ye X, Zhang HM, Hanson P, Zhao G, Tong L, Xie R, Yang D.
    PLoS Pathog; 2017 Dec 31; 13(12):e1006744. PubMed ID: 29220410
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of Coxsackievirus-associated dystrophin cleavage prevents cardiomyopathy.
    Lim BK, Peter AK, Xiong D, Narezkina A, Yung A, Dalton ND, Hwang KK, Yajima T, Chen J, Knowlton KU.
    J Clin Invest; 2013 Dec 31; 123(12):5146-51. PubMed ID: 24200690
    [Abstract] [Full Text] [Related]

  • 6. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy.
    Badorff C, Lee GH, Lamphear BJ, Martone ME, Campbell KP, Rhoads RE, Knowlton KU.
    Nat Med; 1999 Mar 31; 5(3):320-6. PubMed ID: 10086389
    [Abstract] [Full Text] [Related]

  • 7. Dystrophin disruption in enterovirus-induced myocarditis and dilated cardiomyopathy: from bench to bedside.
    Badorff C, Knowlton KU.
    Med Microbiol Immunol; 2004 May 31; 193(2-3):121-6. PubMed ID: 12920582
    [Abstract] [Full Text] [Related]

  • 8. Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy.
    Westermann D, Savvatis K, Lindner D, Zietsch C, Becher PM, Hammer E, Heimesaat MM, Bereswill S, Völker U, Escher F, Riad A, Plendl J, Klingel K, Poller W, Schultheiss HP, Tschöpe C.
    Circulation; 2011 Nov 08; 124(19):2082-93. PubMed ID: 21986287
    [Abstract] [Full Text] [Related]

  • 9. Expression of apoptosis-related proteins in experimental coxsackievirus myocarditis.
    Colston JT, Chandrasekar B, Freeman GL.
    Cardiovasc Res; 1998 Apr 08; 38(1):158-68. PubMed ID: 9683918
    [Abstract] [Full Text] [Related]

  • 10. Nitric oxide inhibits viral replication in murine myocarditis.
    Lowenstein CJ, Hill SL, Lafond-Walker A, Wu J, Allen G, Landavere M, Rose NR, Herskowitz A.
    J Clin Invest; 1996 Apr 15; 97(8):1837-43. PubMed ID: 8621766
    [Abstract] [Full Text] [Related]

  • 11. The role of inducible nitric oxide synthase in the host response to Coxsackievirus myocarditis.
    Zaragoza C, Ocampo C, Saura M, Leppo M, Wei XQ, Quick R, Moncada S, Liew FY, Lowenstein CJ.
    Proc Natl Acad Sci U S A; 1998 Mar 03; 95(5):2469-74. PubMed ID: 9482909
    [Abstract] [Full Text] [Related]

  • 12. Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis.
    Li K, Xu W, Guo Q, Jiang Z, Wang P, Yue Y, Xiong S.
    Circ Res; 2009 Aug 14; 105(4):353-64. PubMed ID: 19608981
    [Abstract] [Full Text] [Related]

  • 13. Molecular and immune mechanisms in the pathogenesis of cardiomyopathy--role of viruses, cytokines, and nitric oxide.
    Matsumori A.
    Jpn Circ J; 1997 Apr 14; 61(4):275-91. PubMed ID: 9152779
    [Abstract] [Full Text] [Related]

  • 14. Soluble coxsackievirus B3 3C protease inhibitor prevents cardiomyopathy in an experimental chronic myocarditis murine model.
    Lim BK, Yun SH, Ju ES, Kim BK, Lee YJ, Yoo DK, Kim YC, Jeon ES.
    Virus Res; 2015 Mar 02; 199():1-8. PubMed ID: 25485472
    [Abstract] [Full Text] [Related]

  • 15. Dissociation of sarcoglycans and the dystrophin carboxyl terminus from the sarcolemma in enteroviral cardiomyopathy.
    Lee GH, Badorff C, Knowlton KU.
    Circ Res; 2000 Sep 15; 87(6):489-95. PubMed ID: 10988241
    [Abstract] [Full Text] [Related]

  • 16. Sustained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders.
    Szalay G, Sauter M, Hald J, Weinzierl A, Kandolf R, Klingel K.
    Am J Pathol; 2006 Dec 15; 169(6):2085-93. PubMed ID: 17148671
    [Abstract] [Full Text] [Related]

  • 17. Interferon-gamma-induced activation of nitric oxide-mediated antiviral activity of macrophages caused by a recombinant coxsackievirus B3.
    Jarasch N, Martin U, Kamphausen E, Zell R, Wutzler P, Henke A.
    Viral Immunol; 2005 Dec 15; 18(2):355-64. PubMed ID: 16035947
    [Abstract] [Full Text] [Related]

  • 18. Nitric oxide from the inducible nitric oxide synthase (iNOS) increases the expression of cytochrome P450 2E1 in iNOS-null hepatocytes in the absence of inflammatory stimuli.
    Zamora R, Vodovotz Y, Alarcon L, Betten B, Loughran PA, Aulak KS, Stuehr DJ, Gibson KF, Billiar TR.
    Arch Biochem Biophys; 2001 Jun 15; 390(2):287-94. PubMed ID: 11396931
    [Abstract] [Full Text] [Related]

  • 19. Nicorandil, a Nitric Oxide Donor and ATP-Sensitive Potassium Channel Opener, Protects Against Dystrophin-Deficient Cardiomyopathy.
    Afzal MZ, Reiter M, Gastonguay C, McGivern JV, Guan X, Ge ZD, Mack DL, Childers MK, Ebert AD, Strande JL.
    J Cardiovasc Pharmacol Ther; 2016 Nov 15; 21(6):549-562. PubMed ID: 26940570
    [Abstract] [Full Text] [Related]

  • 20. Role of inducible nitric-oxide synthase in regulation of whole-cell current in lung epithelial cells.
    Kamosinska B, Radomski A, Man SF, Radomski MW, Duszyk M.
    J Pharmacol Exp Ther; 2000 Nov 15; 295(2):500-5. PubMed ID: 11046081
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.